Norgestrel 0.075 mg tablets

DRUG2 trials

Sponsors

HRA Pharma

Conditions

Contraception

Phase 3

A Study of Oral Contraception Under Simulated OTC Conditions

TerminatedNCT03559010

HRA PharmaContraception

Start: 2018-04-27End: 2018-11-14Updated: 2022-04-04

Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use

CompletedNCT04112095

HRA PharmaContraception

Start: 2019-09-06End: 2021-08-05Updated: 2022-05-20